No profile data available.
DarioHealth Corp. (DRIO) is a healthcare company in the chemical laboratory testing equipment industry, based in New York, United States, with about 160 full-time employees.
It reported revenue of $22.36 million for fiscal year 2025, down 17.3% from fiscal year 2024, and net income of -$61.74 million. Its market capitalization was $56.84 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
DarioHealth reported $22.36 million in revenue for fiscal year 2025, down 17.3% from $27.04 million in fiscal year 2024.
$56.84 million as of October 9, 2026.
Listed companies of a similar size in the same industry (chemical laboratory testing equipment) include Senseonics Holdings, Inc. (SENS), OraSure Technologies, Inc. (OSUR), Anbio Biotechnology (NNNN), Intelligent Bio Solutions Inc. (INBS).